Macquarie Group Ltd. acquired a new position in Pro-Dex Inc (NASDAQ:PDEX) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 29,230 shares of the medical instruments supplier’s stock, valued at approximately $209,000. Macquarie Group Ltd. owned approximately 0.67% of Pro-Dex at the end of the most recent reporting period.

Separately, Ascendiant Capital Markets reissued a “buy” rating and issued a $9.00 price objective (up from $8.00) on shares of Pro-Dex in a research note on Friday, September 8th.

Shares of Pro-Dex Inc (NASDAQ:PDEX) opened at $7.05 on Thursday. Pro-Dex Inc has a 52 week low of $4.30 and a 52 week high of $8.00.

TRADEMARK VIOLATION NOTICE: This story was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this story on another site, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark laws. The original version of this story can be read at https://www.thecerbatgem.com/2017/12/21/macquarie-group-ltd-acquires-new-position-in-pro-dex-inc-pdex.html.

Pro-Dex Profile

Pro-Dex, Inc (Pro-Dex) designs and produces surgical and dental instruments and motion control products used in the medical, factory automation and scientific research industries. The Company operates through four segments: Pro-Dex, OMS, Fineline and Engineering Services Division (ESD). The Pro-Dex segment provides primarily medical and dental instruments using shared production and assembly machines and workforce.

Want to see what other hedge funds are holding PDEX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pro-Dex Inc (NASDAQ:PDEX).

Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.